Allegaert, K., Rayyan, M., Cossey, V. and Van Geet, C. 2015. Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM). 4, 1 (Jan. 2015), e040104. DOI:https://doi.org/10.7363/040104.